sh_microtiterplatte_h BÜHLMANN calprotectin assays appear in more than 50 clinical publications - More than 50 independent publications have proven the clinical performance and reliability of our fecal calprotectin assays in diagnosis and monitoring of IBD patients. The BÜHLMANN fCAL® ELISA can therefore be considered as the gold standard in fecal calprotectin testing. Check out our key literature list now
Infliximab 950x350 First Quantum Blue® Infliximab Poster presented at ECCO 2016 - At the ECCO IBD meeting 2016 in Amsterdam the first poster on the performance of the BÜHLMANN Quantum Blue® Infliximab rapid test was presented, including data on high correlations to the Sanquin and Leuven  infliximab ELISA tests. The reaction from attendees was enthusiastic, and the application for a high quality quantitative rapid tool to measure
sh_216375733_b Flow CAST® in Drug Development – Webinar - Webinar – Use Basophils as Biomarker for Potency and Efficacy of Drugs in Development with Flow CAST®  Inhibitors of PI3K and BTK pathways are a large focus for pharmaceutical companies with several small molecule inhibitors currently at different stages of development. Enzymatic assays to measure the direct activity of compounds are available in the market




DGKL 2016

Date: 28 – 30 September 2016

Place: Mannheim, Germany

Deutscher Kongress der Laboratoriumsmedizin 2016. Besuchen Sie unseren Stand 353.

Deutscher Allergiekongress 2016

Date: 29 September – 1 October 2016

Place: Berlin, Germany

11. Deutscher Allergiekongress. Besuchen Sie unseren Stand A5.


Date: 30 September – 1 October 2016

Place: Paris, France


UEG Week 2016

Date: 15 – 19 October 2016

Place: Vienna, Austria

23rd United European Gastroenterology Week. Visit us at booth #X2/31.